| Literature DB >> 11983050 |
Abstract
Big projects in biology - such as the human genome project and a number of related and ensuing enterprises - require big funding. A new tradition is growing in which some types of basic research take place within commercial organizations. This article reviews some of the reasons for this and some of the key players, in the USA, Europe and Japan, and highlights some issues to be considered when deciding whether particular research belongs in a company rather than an academic setting.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11983050 PMCID: PMC139341 DOI: 10.1186/gb-2002-3-4-comment2004
Source DB: PubMed Journal: Genome Biol ISSN: 1474-7596 Impact factor: 13.583